To maintain growth post-Keytruda, Merck will need to successfully commercialize its pipeline products and expand into new therapeutic areas. The company’s recent deal with Hansoh Pharma for ...

Merck built the new plant on the 262-acre campus it has occupied since 2004, where the pharma giant produces a variety of vaccines including shots to prevent chickenpox, measles and rubella.

Merck (MRK) announced the opening of a new, $1B, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site. This expansion of our Durham plant is a ...

Armata Pharmaceuticals Logo (PRNewsfoto/Armata Pharmaceuticals, Inc.) Proceeds from the new financing transaction will be used to advance the Company's lead therapeutic phage candidates, ...

H.C. Wainwright lowered the firm’s price target on UroGen Pharma (URGN) to $55 from $64 and keeps a Buy rating on the shares. The company reported a “modest” revenue miss, but its long-term ...

05:51 – What Ben thinks pharma is doing wrong with regards to publication bias and the lack of transparency. 13:54 – What organisations Ben thinks are making a positive change in this area.

This ensures all personnel are current with the latest regulatory requirements and best practices in transparency reporting. For emerging pharma and medical device companies navigating the complex ...

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing ...

–Treatment with HU6 led to significant reductions in body fat and abdominal visceral fat while preserving skeletal muscle in patients with obesity-related heart failure with preserved ejection ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...